172 related articles for article (PubMed ID: 22718313)
21. Bovine papillomavirus type 1 (BPV1) and BPV2 are closely related serotypes.
Shafti-Keramat S; Schellenbacher C; Handisurya A; Christensen N; Reininger B; Brandt S; Kirnbauer R
Virology; 2009 Oct; 393(1):1-6. PubMed ID: 19729180
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
[TBL] [Abstract][Full Text] [Related]
23. Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity.
Pan H; Li Z; Wang J; Song S; Wang D; Wei M; Gu Y; Zhang J; Li S; Xia N
Vaccine; 2017 May; 35(24):3222-3231. PubMed ID: 28483196
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods.
Matić S; Masenga V; Poli A; Rinaldi R; Milne RG; Vecchiati M; Noris E
Plant Biotechnol J; 2012 May; 10(4):410-21. PubMed ID: 22260326
[TBL] [Abstract][Full Text] [Related]
25. Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.
Matić S; Rinaldi R; Masenga V; Noris E
BMC Biotechnol; 2011 Nov; 11():106. PubMed ID: 22085463
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.
Shoji Y; Prokhnevsky A; Leffet B; Vetter N; Tottey S; Satinover S; Musiychuk K; Shamloul M; Norikane J; Jones RM; Chichester JA; Green BJ; Streatfield SJ; Yusibov V
Hum Vaccin Immunother; 2015; 11(1):118-23. PubMed ID: 25483524
[TBL] [Abstract][Full Text] [Related]
27. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.
Kirnbauer R; Chandrachud LM; O'Neil BW; Wagner ER; Grindlay GJ; Armstrong A; McGarvie GM; Schiller JT; Lowy DR; Campo MS
Virology; 1996 May; 219(1):37-44. PubMed ID: 8623552
[TBL] [Abstract][Full Text] [Related]
28. Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles.
Li T; Lin H; Zhang Y; Li M; Wang D; Che Y; Zhu Y; Li S; Zhang J; Ge S; Zhao Q; Xia N
Vaccine; 2014 Apr; 32(17):1921-31. PubMed ID: 24530406
[TBL] [Abstract][Full Text] [Related]
29. Bovine serological response to a recombinant BPV-1 major capsid protein vaccine.
Jin XW; Cowsert L; Marshall D; Reed D; Pilacinski W; Lim LY; Jenson AB
Intervirology; 1990; 31(6):345-54. PubMed ID: 2177743
[TBL] [Abstract][Full Text] [Related]
30. Novel Production of Bovine Papillomavirus Pseudovirions in Tobacco Plants.
Pietersen I; van Zyl A; Rybicki E; Hitzeroth I
Pathogens; 2020 Nov; 9(12):. PubMed ID: 33260725
[TBL] [Abstract][Full Text] [Related]
31. High-level expression and enrichment of norovirus virus-like particles in plants using modified geminiviral vectors.
Diamos AG; Mason HS
Protein Expr Purif; 2018 Nov; 151():86-92. PubMed ID: 29908914
[TBL] [Abstract][Full Text] [Related]
32. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
[TBL] [Abstract][Full Text] [Related]
33. Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.
Masuda A; Lee JM; Miyata T; Sato T; Hayashi S; Hino M; Morokuma D; Karasaki N; Mon H; Kusakabe T
J Gen Virol; 2018 Jul; 99(7):917-926. PubMed ID: 29851377
[TBL] [Abstract][Full Text] [Related]
34. Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco.
Lenzi P; Scotti N; Alagna F; Tornesello ML; Pompa A; Vitale A; De Stradis A; Monti L; Grillo S; Buonaguro FM; Maliga P; Cardi T
Transgenic Res; 2008 Dec; 17(6):1091-102. PubMed ID: 18491213
[TBL] [Abstract][Full Text] [Related]
35. [Expression, purification and immunogenicity of human papillomavirus type 11 virus-like particles from Escherichia coli].
Yan C; Li S; Wang J; Wei M; Huang B; Zhuang Y; Li Z; Pan H; Zhang J; Xia N
Wei Sheng Wu Xue Bao; 2009 Nov; 49(11):1527-33. PubMed ID: 20112683
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic.
Fernández-San Millán A; Ortigosa SM; Hervás-Stubbs S; Corral-Martínez P; Seguí-Simarro JM; Gaétan J; Coursaget P; Veramendi J
Plant Biotechnol J; 2008 Jun; 6(5):427-41. PubMed ID: 18422886
[TBL] [Abstract][Full Text] [Related]
37. Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses.
Hainisch EK; Brandt S; Shafti-Keramat S; Van den Hoven R; Kirnbauer R
Equine Vet J; 2012 Jan; 44(1):107-11. PubMed ID: 21895749
[TBL] [Abstract][Full Text] [Related]
38. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
39. Bovine papillomavirus type 1 monoclonal antibodies.
Gorra JB; Lancaster WD; Kurman RJ; Jenson AB
J Natl Cancer Inst; 1985 Jul; 75(1):121-5. PubMed ID: 2989600
[TBL] [Abstract][Full Text] [Related]
40. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.
Hassan SW; Waheed MT; Müller M; Clarke JL; Shinwari ZK; Lössl AG
Hum Vaccin Immunother; 2014; 10(10):2975-82. PubMed ID: 25483463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]